Alnylam Pharmaceuticals
ALNY
#448
Rank
โ‚น4.705 T
Marketcap
โ‚น35,618
Share price
-2.46%
Change (1 day)
73.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company